CY1926A - Novel 3-piperidinyl-1,2-benzisoxazoles - Google Patents

Novel 3-piperidinyl-1,2-benzisoxazoles

Info

Publication number
CY1926A
CY1926A CY192689A CY192689A CY1926A CY 1926 A CY1926 A CY 1926A CY 192689 A CY192689 A CY 192689A CY 192689 A CY192689 A CY 192689A CY 1926 A CY1926 A CY 1926A
Authority
CY
Cyprus
Prior art keywords
compounds
benzisoxazoles
piperidinyl
novel
4alkyl
Prior art date
Application number
CY192689A
Other languages
English (en)
Inventor
Cornelus Gerardus Mari Janssen
Alfonsus Guilielmus Knaeps
Ludo Edmond Josephine Kennis
Jan Vandenberk
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CY1926A publication Critical patent/CY1926A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
CY192689A 1988-11-07 1989-10-30 Novel 3-piperidinyl-1,2-benzisoxazoles CY1926A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26785788A 1988-11-07 1988-11-07

Publications (1)

Publication Number Publication Date
CY1926A true CY1926A (en) 1989-10-30

Family

ID=23020416

Family Applications (2)

Application Number Title Priority Date Filing Date
CY192689A CY1926A (en) 1988-11-07 1989-10-30 Novel 3-piperidinyl-1,2-benzisoxazoles
CY200700025C CY2007025I2 (el) 1988-11-07 2007-10-15 3-piperidinyl-1,2-benzisoxazoles

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY200700025C CY2007025I2 (el) 1988-11-07 2007-10-15 3-piperidinyl-1,2-benzisoxazoles

Country Status (21)

Country Link
EP (1) EP0368388B1 (de)
JP (1) JP2758045B2 (de)
KR (1) KR0146053B1 (de)
AT (1) ATE122349T1 (de)
AU (1) AU614437B2 (de)
CA (1) CA2000786C (de)
CL (1) CL43432B (de)
CY (2) CY1926A (de)
DE (2) DE68922577T2 (de)
DK (1) DK169923B1 (de)
ES (1) ES2075036T3 (de)
FI (1) FI92201C (de)
HK (1) HK131696A (de)
IE (1) IE66370B1 (de)
IL (1) IL92208A0 (de)
LU (1) LU91362I2 (de)
NL (1) NL300298I2 (de)
NO (2) NO173015C (de)
NZ (1) NZ231062A (de)
PT (1) PT92206B (de)
ZA (1) ZA898436B (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9008850D0 (en) * 1990-04-19 1990-06-13 Janssen Pharmaceutica Nv Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones
AU672182B2 (en) * 1991-11-27 1996-09-26 Novo Nordisk A/S Piperidine derivatives and their use in treating psychosis
US5378714A (en) * 1991-11-27 1995-01-03 Novo Nordisk A/S Antipsychotic piperidine derivatives
ES2050069B1 (es) * 1992-07-10 1994-12-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-il)piperidino)etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido(1,2-a) pirimidin-4-ona.
DK60793D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
DK60593D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
ES2236700T3 (es) * 1993-11-19 2005-07-16 Janssen Pharmaceutica N.V. 1,2-benzazoles microencapsulados.
EP0730594B1 (de) * 1993-11-23 1999-09-08 Janssen Pharmaceutica N.V. 9-HYDROXY-PYRIDO [1,2-a] PYRIMIDIN-4-ON-ETHER-DERIVATE
ES2085234B1 (es) * 1994-02-24 1997-01-16 Vita Invest Sa Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
US6028083A (en) * 1997-07-25 2000-02-22 Hoechst Marion Roussel, Inc. Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
ES2141671B1 (es) * 1997-12-26 2001-01-01 Vita Invest Sa Compuesto pirimidinico activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
WO1999059589A1 (en) * 1998-05-18 1999-11-25 Sepracor Inc. (-)-hydroxyrisperidone compositions and methods
AU3900499A (en) * 1998-05-18 1999-12-06 Sepracor, Inc. (+)-hydroxyrisperidone compositions and methods
US6342488B1 (en) 1998-08-18 2002-01-29 Sepracor, Inc. Phosphonorisperidone and sulforisperidone compositions and methods
ES2197801B1 (es) 2002-03-05 2005-03-16 Ferrer Internacional,S.A Procedimiento de obtencion de la 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il) piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a ) pirimidin-4-ona.
KR20040025224A (ko) * 2002-09-18 2004-03-24 주식회사 대웅 2-(2-메틸-4-옥소-6,7,8,9-테트라하이드로-4Ｈ-피리도[1,2-ａ]피리미딘-3-일)아세트알데히드 및 그 제조방법
EP1560814A1 (de) 2002-11-13 2005-08-10 Synthon B.V. Verfahren zur herstellung von risperidon und zwischenprodukte
EP1791839B1 (de) * 2004-09-09 2015-06-10 Janssen Pharmaceutica NV Herstellung von 9-hydroxy-3-(2-hydroxyethyl)-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-on und kristallen davon
US20070197591A1 (en) 2005-12-12 2007-08-23 Sandra Boom Use of paliperidone for the treatment of a mental disorder in a psychiatric patient with reduced hepatic function
EP2133352A3 (de) * 2006-08-14 2010-01-13 Teva Pharmaceutical Industries Ltd. Kristallform von 9-Hydroxy-Risperidon (Paliperidon)
US20080177067A1 (en) * 2006-08-14 2008-07-24 Ben-Zion Dolitzky Crystal forms of 9-hydroxy-risperidone (paliperidone)
EP2133351A3 (de) * 2006-08-14 2010-01-13 Teva Pharmaceutical Industries Ltd. Kristallform von 9-Hydroxy-Risperidon (Paliperidon)
WO2008024415A2 (en) * 2006-08-23 2008-02-28 Teva Pharmaceutical Insustries Ltd. Process for the synthesis of cmhtp and intermediates thereof
US7820816B2 (en) 2006-08-23 2010-10-26 Teva Pharmaceutical Industries Ltd. Process for the synthesis of CMHTP and intermediates thereof
WO2008087557A2 (en) * 2007-01-08 2008-07-24 Actavis Group Ptc Ehf An improved process for preparation of 9-hydroxy-3-(2-chloroethyl)- 2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one hydrochloride
US8314110B2 (en) * 2007-04-19 2012-11-20 Youxin Li Compounds for treating mental disorders, and preparation and uses thereof
WO2009010988A1 (en) * 2007-07-19 2009-01-22 Natco Pharma Limited An improved, industrially viable process for the preparation of high purity paliperidone
EP2178872A1 (de) * 2007-07-27 2010-04-28 Synthon B.V. Paliperidonderivate
WO2009045489A2 (en) * 2007-10-03 2009-04-09 Teva Pharmaceutical Industries Ltd. Process for the synthesis of cmhtp, a paliperidone intermediate
NZ584370A (en) * 2007-10-09 2011-04-29 Cipla Ltd Processes for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes
US7977480B2 (en) 2007-12-10 2011-07-12 Synthon Bv Synthesis of paliperidone
WO2009116071A2 (en) * 2008-02-05 2009-09-24 Watson Pharma Private Limited An improved process for preparation of paliperidone
WO2009130710A2 (en) * 2008-04-21 2009-10-29 Glenmark Generics Limited A process for the preparation of paliperidone intermediates
EP2303877B1 (de) 2008-05-29 2017-02-15 Inke, S.A. Verfahren zur herstellung von paliperidon und zwischenprodukte dafür
WO2010004578A2 (en) * 2008-06-16 2010-01-14 Msn Laboratories Limited Novel and improved processes for the preparation of paliperidone
EP2321311B1 (de) * 2008-07-11 2012-09-19 Synthon B.V. Synthese von paliperidon
EP2318405A2 (de) 2008-07-11 2011-05-11 Synthon B.V. Paliperidonketon
SI22856A (sl) * 2008-07-31 2010-02-26 Krka, Tovarna Zdravil, D.D., Novo Mesto Proces za pripravo paliperidona
EP2161019A1 (de) 2008-09-05 2010-03-10 KRKA, D.D., Novo Mesto Verlängerte Freisetzung von einer pharmazeutischen Mehrteilchenzusammensetzung mit Paliperidon
EP2199293A1 (de) 2008-12-22 2010-06-23 Chemo Ibérica, S.A. Einschrittverfahren zur Herstellung von Paliperidon und sein Oxalat -salz
EP2202234A1 (de) 2008-12-24 2010-06-30 Laboratorios Lesvi, S.L. Reinigung von Paliperidon
SI2275423T1 (sl) 2009-07-13 2012-06-29 Krka D.D., Novo Mesto Postopek za sintezo paliperidona
WO2011018246A2 (en) 2009-08-13 2011-02-17 Synthon B.V. Controlled release paliperidone composition
EP2343296A1 (de) 2009-12-01 2011-07-13 Chemo Ibérica, S.A. Verfahren zur Aufreinigung von Paliperidon
WO2011074017A1 (en) * 2009-12-17 2011-06-23 Alkem Laboratories Ltd. A novel process for the preparation of paliperidone
US8088594B2 (en) * 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
WO2012035554A1 (en) * 2010-09-14 2012-03-22 Megafine Pharma (P) Ltd. An improved process for the preparation of highly pure paliperidone
WO2012068161A1 (en) 2010-11-15 2012-05-24 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
CN102153552B (zh) * 2011-03-01 2012-08-22 吉林大学 两种帕潘立酮药物共晶及其制备方法
CN102206210B (zh) * 2011-04-01 2014-07-02 常州市第四制药厂有限公司 一种6-氟-3-(4-哌啶基)-1，2-苯并异噁唑盐酸盐的生产方法
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
EP3083569B1 (de) 2013-12-20 2022-01-26 Agenebio, Inc. Benzodiazepinderivate, zusammensetzungen und verfahren zur behandlung von kognitiven störungen
CN108026107B (zh) 2015-06-19 2021-07-30 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂环庚三烯衍生物、组合物和方法
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
BR112019012821A2 (pt) 2016-12-19 2019-11-26 Agenebio Inc derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo
WO2019162746A1 (en) * 2018-02-21 2019-08-29 Zenvision Pharma Llp Novel derivatives of paliperidone and process for the preparation thereof
CA3104478A1 (en) 2018-06-19 2019-12-26 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
WO2024039886A1 (en) 2022-08-19 2024-02-22 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment
CN116003404A (zh) * 2022-12-14 2023-04-25 杭州同舟生物技术有限公司 一种利培酮人工半抗原、人工抗原及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles

Also Published As

Publication number Publication date
KR0146053B1 (ko) 1998-08-17
LU91362I2 (fr) 2007-11-12
CL43432B (es) 2005-06-03
CY2007025I1 (el) 2009-11-04
CY2007025I2 (el) 2009-11-04
ATE122349T1 (de) 1995-05-15
PT92206B (pt) 1995-07-06
NO173015C (no) 1993-10-13
DE122007000081I2 (de) 2010-01-28
ES2075036T3 (es) 1995-10-01
JP2758045B2 (ja) 1998-05-25
KR910009700A (ko) 1991-06-28
AU4443689A (en) 1990-05-10
DE68922577T2 (de) 1995-09-28
NO2007017I1 (no) 2008-01-14
PT92206A (pt) 1990-05-31
FI92201C (fi) 1994-10-10
EP0368388A3 (de) 1991-07-17
FI895261A0 (fi) 1989-11-06
DK169923B1 (da) 1995-04-03
DK551989D0 (da) 1989-11-06
DE68922577D1 (de) 1995-06-14
FI92201B (fi) 1994-06-30
CA2000786C (en) 1999-01-26
HK131696A (en) 1996-07-26
NO894411L (no) 1990-05-08
NO173015B (no) 1993-07-05
NZ231062A (en) 1991-09-25
NL300298I2 (nl) 2008-03-03
IE893564L (en) 1990-05-07
IE66370B1 (en) 1995-12-27
EP0368388A2 (de) 1990-05-16
AU614437B2 (en) 1991-08-29
JPH02191276A (ja) 1990-07-27
NO894411D0 (no) 1989-11-06
DK551989A (da) 1990-05-08
CA2000786A1 (en) 1990-05-07
NL300298I1 (nl) 2007-12-03
DE122007000081I1 (de) 2008-02-28
EP0368388B1 (de) 1995-05-10
IL92208A0 (en) 1990-07-26
NO2007017I2 (no) 2010-01-25
ZA898436B (en) 1991-07-31

Similar Documents

Publication Publication Date Title
HK131696A (en) 3-piperidinyl-1,2-benzisoxazoles
EP0151824A3 (en) N-(4-piperidinyl) bicyclic condesed 2-imidazolamine derivatives
ZA895978B (en) Antipsychotic 3-piperazinylbenzazole derivatives
AU1810988A (en) Novel n-(4-piperidinyl)bicyclic condensed 2-imidazolamine derivatives
HUT51622A (en) Process for producing 3-piperidinole-indazole derivatives and pharmaceutical preparations having effect against high blood pressure containing these compounds as active substance